Wealth Enhancement Advisory Services’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
14,830
+245
+2% +$12.6K ﹤0.01% 2965
2026
Q1
$392K Buy
14,585
+4,603
+46% +$299K ﹤0.01% 2525
2025
Q4
$629K Buy
9,982
+857
+9% +$52.5K ﹤0.01% 2306
2025
Q3
$574K Sell
9,125
-446
-5% -$31K ﹤0.01% 2255
2025
Q2
$765K Buy
9,571
+1,134
+13% +$94.8K ﹤0.01% 1908
2025
Q1
$725K Buy
8,437
+122
+1% +$10K ﹤0.01% 1798
2024
Q4
$649K Buy
8,315
+1,030
+14% +$80K ﹤0.01% 1803
2024
Q3
$525K Sell
7,285
-41
-0.6% -$2.9K ﹤0.01% 1806
2024
Q2
$504K Sell
7,326
-35
-0.5% -$2.37K ﹤0.01% 1648
2024
Q1
$534K Sell
7,361
-25
-0.3% -$1.67K ﹤0.01% 1544
2023
Q4
$452K Buy
7,386
+458
+7% +$27.2K ﹤0.01% 1568
2023
Q3
$396K Buy
+6,928
New +$419K ﹤0.01% 1572

Other funds holding PBH

Wealth Enhancement Advisory Services's PBH Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Prestige Consumer Healthcare (PBH) stake by 1.7% in Q2 2026, buying an estimated $12.6K and bringing the position to 14,830 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #2965.

Wealth Enhancement Advisory Services first reported a position in PBH in Q3 2023 and has held it in 12 quarters since. The position peaked at $765K in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Wealth Enhancement Advisory Services held 14,830 shares of Prestige Consumer Healthcare worth $381K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 245 Prestige Consumer Healthcare shares in Q2 2026, an estimated $12.6K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2965 holding.
  • Wealth Enhancement Advisory Services first reported a position in Prestige Consumer Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Prestige Consumer Healthcare position peaked at $765K in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.